Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



Xenogesis Increases Capabilities, Adding CYP Induction and Gene Expression Assay Services to its Portfolio

14 October 2016: Nottingham, UK - XenoGesis has invested in a state of the art Agilent AriaMx Real-time PCR system, further expanding its quantitative PCR capabilities and adding CYP induction assays to its portfolio of services.

Read the rest of entry »

£500k Accelerator for Life Sciences Startups Launches at Alderley Park

14 October 2016: Macclesfield, UK - Life sciences startups across the North are set for a boost with the launch of a new £500k accelerator.  The North of England Life Science Accelerator (NELSA) was announced at the fifth annual BioCap Conference, held this week (September 29) at the multi-million pound Alderley Park science campus in Cheshire.

Read the rest of entry »

Sygnature Discovery Expands DMPK Team with Appointment of Dr. Edward Browne

13 October 2016: Nottingham, UK - Sygnature announces the expansion of its DMPK team with the appointment of Dr Ed Browne as Associate Director of DMPK.

Read the rest of entry »

Oxford Immunotec Acquires Immunetics, Inc.

12 October 2016: Oxford, UK & Marlborough, USA - Oxford Immunotec Global PLC a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of under-served immune-regulated conditions, announced it has today closed a transaction to acquire Immunetics, Inc., a Massachusetts based diagnostics company focused on developing specialized tests for infectious diseases, such as Lyme disease.

Read the rest of entry »

Immunocore Appoints Paul Fry as Chief Financial Officer

12 October 2016:  Oxford, UK - Immunocore Limited, a world-leading biotechnology company developing novel biological drugs to treat cancer, infectious diseases and autoimmune diseases, today announces the appointment of Paul Fry as Chief Financial Officer.

Read the rest of entry »

Escalating Threat of Cyber Crime in Life Sciences and Healthcare

11 October 2016: Oxford, UK - From cyber blackmail to IP theft life science companies find themselves at increasing risk of online attack. Medical records are the new currency among cyber-criminals, with black market values set at ten times higher than credit card information. UK hospitals are not exempt from this burgeoning threat, as cyber-criminals are targeting information of value wherever it resides, including within healthcare organisations. UK hospitals carry extremely sensitive medical records, as do their US counterparts, which recently succumbed to a ransomware attack causing significant damage.

Read the rest of entry »

Abingdon Health Announces CE Marking of ELISA Assay with Utility in Multiple Myeloma

11 October 2016: Oxford, UK - From cyber blackmail to IP theft life science companies find themselves at increasing risk of online attack. Medical records are the new currency among cyber-criminals, with black market values set at ten times higher than credit card information. UK hospitals are not exempt from this burgeoning threat, as cyber-criminals are targeting information of value wherever it resides, including within healthcare organisations. UK hospitals carry extremely sensitive medical records, as do their US counterparts, which recently succumbed to a ransomware attack causing significant damage.

Read the rest of entry »

OBN Appoints Three New Directors to Enhance Board Expertise

10 October 2016: Abingdon, UK - OBN, the membership organisation supporting the UK’s innovative life sciences companies, announced today that it had appointed Mark Anderson, Brian Hargreaves and Ross Sommerville to its Board of Directors. Between them they add considerable sector experience to the Board, bringing legal, investment, commercial and general management expertise. OBN also announced that due to the demands of their respective roles outside of OBN, Stewart Sharpe and Steven Lee have stepped down from the Board.

Read the rest of entry »

OBN Awards 2016 – Winners Recognised at Industry Leading Event

07 October 2016: Abingdon, UK – OBN Ltd, the membership organisation supporting the UK’s innovative life sciences companies, are delighted to announce the winners of the prestigious OBN Awards 2016 that were presented last night in front of a sold-out audience of over 250 leaders from Biotech, Medtech and Investment companies at the Town Hall in Oxford.

Read the rest of entry »

Summit Presents Preclinical DMD Data at 21st Congress of World Muscle Society

06 October 2016: Oxford, UK - Summit Therapeutics plc, the drug discovery and development company advancing therapies for Duchenne muscular dystrophy ('DMD') and Clostridium difficile infection, announces the presentation of preclinical data at the 21st International Congress of the World Muscle Society, which is taking place in Granada, Spain from 4-8 October 2016.  The data include further findings from Summit's programme to develop tools to measure biomarkers of muscle health for use in patient clinical trials evaluating utrophin modulator therapies.

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.